Progyny (PGNY) Gains from Sales and Divestitures (2020 - 2021)
Progyny (PGNY) reported Gains from Sales and Divestitures of $201916.0 for Q4 2021, up 319.82% year-over-year from $48096.0 in Q4 2020, and up 319.82% on a QoQ basis from $48096.0 in Q4 2020.
Progyny (PGNY) has 2 years of Gains from Sales and Divestitures data on file, last reported at $201916.0 in Q4 2021.
- Quarterly Gains from Sales and Divestitures rose 319.82% year-over-year to $201916.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $201916.0 (up 319.82% YoY) and the FY2021 annual result came in at $201916.0, up 319.82% from the prior year.
- Gains from Sales and Divestitures advanced to $201916.0 in Q4 2021 per PGNY's latest filing, from $48096.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $201916.0 in Q4 2021 and bottomed at $48096.0 in Q4 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Unitedhealth | 345.31 Bn | 315.51 Bn | 98.90 Bn |
| 2 | Cvs Health | 115.41 Bn | 103.79 Bn | 4.43 Bn |
| 3 | Elevance Health | 88.60 Bn | 53.18 Bn | 13.88 Bn |
| 4 | Cigna | 72.05 Bn | 64.43 Bn | -44.29 Bn |
| 5 | Humana | 39.05 Bn | 17.15 Bn | 4.00 Bn |
| 6 | Centene | 30.50 Bn | 6.84 Bn | 49.24 Bn |
| 7 | Molina Healthcare | 9.31 Bn | 60.65 Mn | 1.53 Bn |
| 8 | Oscar Health | 6.86 Bn | 63.05 Mn | -3.22 Bn |
| 9 | Alignment Healthcare | 2.69 Bn | 1.96 Bn | 135.85 Mn |
| 10 | Progyny | 2.12 Bn | 1.90 Bn | 83.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 201,916.00 |
| Dec 31, 2021 | 201,916.00 |
| Dec 31, 2020 | 48,096.00 |
| Dec 31, 2020 | 48,096.00 |